Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) Depreciation & Amortization

Annual D&A

$1.10M$569.00K+107.97%

Summary

Current Value
As of today, MDGL annual D&A is $1.10M, up +107.97% on
Historical Performance
MDGL annual D&A is up +170.62% over the past 3 years, and up +878.57% over the past 5 years
All-Time High Comparison
MDGL annual D&A is currently -70.01% below its historical high of $3.66M set on
3-Year Low Comparison
MDGL annual D&A is +134.69% above its 3-year low of $467.00K reached on an earlier date
Sector Comparison
MDGL annual D&A is higher than 39.82% of companies in Healthcare sector

Depreciation & Amortization Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual D&A$1.10M+108.0%+170.6%+878.6%-55.5%
Quarterly D&A$358.00K+20.1%+195.9%+211.3%-24.3%
TTM D&A$1.48M+68.8%+232.7%+285.6%-25.6%
Price$493.90+62.6%+64.6%+340.2%+113.8%
Annual SG&A$0.00-100.0%-100.0%-100.0%-100.0%
Annual Total Expenses$678.01M+78.2%+179.6%+613.9%+964.3%
Annual Operating Expenses$671.78M+76.5%+177.0%+607.3%+954.5%
Annual Revenue$180.13M+100.0%+100.0%+100.0%+24.9%

Depreciation & Amortization Highs

MDGL Annual D&A Highs Comparison
PeriodHighDateCurrent
3Y$1.10Mat high
5Y$1.10Mat high
All$3.66M-70.0%

Depreciation & Amortization Lows

MDGL Annual D&A Lows Comparison
PeriodLowDateCurrent
3Y$467.00KN/A+134.7%
5Y$405.00K+170.6%
All$0.00N/A

Depreciation & Amortization History

YearValueChange
$1.10M+108.0%
$527.00K+12.8%
$467.00K+15.3%
$405.00K-14.0%
$471.00K+320.5%
$112.00K+16.7%
$96.00K+24.7%
$77.00K>+9,900.0%
$200.00>+9,900.0%
$0.00-100.0%
$673.00K+30.4%
YearValueChange
$516.00K-30.1%
$738.00K-49.6%
$1.46M-24.3%
$1.93M-21.5%
$2.46M-9.3%
$2.72M-18.9%
$3.35M-8.3%
$3.66M+48.9%
$2.46M+58.7%
$1.55M+53.8%
$1.01M-

FAQ

  • What is the current annual D&A of MDGL?

    As of today, MDGL annual D&A is $1.10M

  • What is 1-year change in MDGL annual D&A?

    MDGL annual D&A is up +107.97% year-over-year

  • What is 3-year change in MDGL annual D&A?

    MDGL annual D&A is up +170.62% over the past 3 years

  • How far is MDGL annual D&A from its all-time high?

    MDGL annual D&A is currently -70.01% below its historical high of $3.66M set on December 31, 2006

  • How does MDGL annual D&A rank versus sector peers?

    MDGL annual D&A is higher than 39.82% of companies in Healthcare sector

  • When is MDGL next annual earnings release?

    The next annual earnings release for MDGL is on

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl